| DC Field | Value | Language |
|---|
| dc.contributor.author | Ermilov, O. V. | - |
| dc.contributor.author | Tretyakov, A. Yu. | - |
| dc.contributor.author | Romasenko, L. V. | - |
| dc.contributor.author | Zhernakova, N. I. | - |
| dc.contributor.author | Rudycheva, E. S. | - |
| dc.date.accessioned | 2024-04-05T09:22:09Z | - |
| dc.date.available | 2024-04-05T09:22:09Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Features of the metabolic syndrome and type 2 diabetes mellitus in schizotypal disorder / O.V. Ermilov, Tretyakov A.Yu., L.V. Romasenko [et al.] // European Journal of Molecular & Clinical Medicine. - 2020. - Vol.7, №2.-P. 122-127. - Refer.: p. 126-127. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/62069 | - |
| dc.description.abstract | To describe the features and mechanisms of development of metabolic syndrome, type 2 diabetes melitus and intermediate states of glycemia in psychosis the occurrence of these disorders, the values of total cholesterol, fractions of high density lipoproteins, very low density lipoproteins, triglycerides, values of atherogenic coefficient, insulinemia, С-peptidemia, insulin resistance the level of glycated hemoglobin in a sample of patients with schizophrenia and in mentally healthy individuals | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | clinical medicine | ru |
| dc.subject | schizophrenia | ru |
| dc.subject | metabolic syndrome | ru |
| dc.subject | diabetes mellitus | ru |
| dc.subject | dyslipidemia | ru |
| dc.subject | insulin | ru |
| dc.subject | insulin resistance | ru |
| dc.subject | C-peptide | ru |
| dc.subject | glycated hemoglobin | ru |
| dc.title | Features of the metabolic syndrome and type 2 diabetes mellitus in schizotypal disorder | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
